ArticleSurgical endoscopy2026
Obstetrical outcomes after transvaginal natural orifice transluminal endoscopic surgery for benign gynecological conditions: a prospective cohort study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundTransvaginal natural orifice transluminal endoscopic surgery (vNOTES) is increasingly used for benign gynecologic conditions; however, evidence regarding subsequent obstetrical outcomes and the optimal interval between surgery and conception remains limited. This study aimed to evaluate pregnancy outcomes after fertility-preserving vNOTES and to assess whether the postoperative interval influences the risk of adverse outcomes.
methodsThis prospective cohort study included 326 women who conceived after fertility-preserving vNOTES performed for benign gynecological diseases with cosmetic considerations between April 2022 and June 2024, along with 326 matched controls without a history of vNOTES during the same period. Post-vNOTES pregnancies were stratified by the interval from surgery to conception (≤ 3, 3-6, and > 6 months). Obstetrical outcomes, including delivery mode, gestational age, neonatal birth weight, maternal complications, preterm birth, and neonatal asphyxia, were compared. Multivariable logistic regression was performed to identify independent risk factors for preterm birth and neonatal asphyxia.
resultsBaseline characteristics were generally comparable, although the control group had higher parity and more prior cesarean deliveries (both p < 0.001). The distribution of surgical indications differed across interval groups (p < 0.001). The vNOTES group had higher rates of assisted reproductive technology and twin pregnancies (both p < 0.001). No significant differences were observed between groups in delivery mode, gestational age at birth, neonatal birth weight, or maternal complications. In regression analyses, twin pregnancy was independently associated with preterm birth (HR 11.736, p < 0.001) and neonatal asphyxia (HR 29.302, p = 0.019), while lower gestational age was also associated with neonatal asphyxia (HR 0.863, p = 0.018). The interval between vNOTES and conception was not associated with adverse outcomes.
conclusionsPregnancy outcomes following vNOTES are comparable to those without prior vNOTES. Early conception after vNOTES does not appear to increase the risk of adverse obstetrical outcomes, supporting vNOTES as a safe fertility-preserving surgical approach without the need for prolonged delay before conception.
trial registrationChiCTR2200059282, registered on April 28, 2022 ( https://www.chictr.org.cn/showproj.html?proj=167900 ).
Indexed as
Identifiers
42443682What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.